Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
MedPlus Health Services Ltd. ( (IN:MEDPLUS) ) has issued an update.
MedPlus Health Services Ltd. announced that its subsidiary, Optival Health Solutions Private Limited, has received suspension orders for drug licenses at two of its stores in Karnataka. The suspensions, issued under the Drugs and Cosmetics Act and Rules, are for one day at a store in Hampi Nagar and three days at a store in Vijayapura, potentially resulting in a revenue loss of approximately Rs 0.91 lacs and Rs 0.54 lacs respectively. This development may impact the company’s financial operations and highlights regulatory challenges in maintaining compliance with drug control standards.
More about MedPlus Health Services Ltd.
MedPlus Health Services Ltd. operates in the healthcare industry, primarily focusing on providing pharmacy retail services. The company is known for its extensive network of stores across India, offering a wide range of pharmaceutical products and health-related services.
YTD Price Performance: -6.21%
Average Trading Volume: 6,186
Current Market Cap: 95.26B INR
See more insights into MEDPLUS stock on TipRanks’ Stock Analysis page.